NCT01893281

The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 78 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate if testosterone solution can raise testosterone hormone levels into the normal range after treatment for up to 9 Weeks, in those participants with a documented history of subtherapeutic levels \[total testosterone \<300 nanograms per deciliter (ng/dL)\] when previously treated with a topical testosterone gel.

Conditions

• Hypogonadism

Interventions

Type	Name	Description
DRUG	Topical Testosterone Solution	Administered topically to axillae.

Timeline

• Start date: 2013-07-01
• Primary completion: 2014-01-01
• Completion: 2014-01-01
• First posted: 2013-07-09
• Last updated: 2014-10-27
• Results posted: 2014-10-27

Locations

21 sites across 1 country: United States